New combo approach for Lung-Limited colorectal cancer shows promise in early trial
NCT ID NCT03599752
First seen Jun 27, 2026 · Last updated Jul 17, 2026 · Updated 2 times
Summary
This phase 2 trial studies whether combining chemotherapy with surgery to remove lung tumors works better than either treatment alone for patients with colorectal cancer that has spread only to the lungs. About 40 participants will be grouped by risk level to see if the combination improves survival or delays cancer return. The goal is to find the best treatment plan for each patient.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Baylor Colllege of Medicine
Houston, Texas, 77030, United States
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
-
Thomas Jefferson University
Philadelphia, Pennsylvania, 19107, United States
-
University Health Network Princess Margaret Cancer Center P2C
Toronto, Ontario, M5G 2M9, Canada
-
University of Montreal
Montreal, Quebec, H3T 1J7, Canada
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug combo shrink Hard-to-Treat tumors?
- Can a new blood test spot colorectal cancer return earlier?
- Can a new immunotherapy combo shrink Hard-to-Treat tumors?
- Breath of life: new test could sniff out gut cancers before they spread
- Gut instinct: listening to bowel sounds may reveal hidden clues about surgical recovery
- Experimental drug combo targets Hard-to-Treat GI cancers